Colgate Palmolive (CL) Capital Expenditures (2009 - 2026)

Colgate Palmolive's Capital Expenditures history runs 18 years deep, the most recent figure standing at -$19.0 million for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 115.32% year-over-year to -$19.0 million in Q1 2026; TTM through Mar 2026 was $421.0 million, a 1503.33% increase from a year earlier, with the FY2025 full-year figure at $564.0 million, up 2114.29% from the prior year.
• Capital Expenditures declined to -$19.0 million in Q1 2026 per CL's latest filing, from $177.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $221.0 million in Q4 2022 and bottomed at -$405.0 million in Q4 2024.
• The 5-year median for Capital Expenditures is $155.0 million (2025), against an average of $112.8 million.
• Across the five-year window, Capital Expenditures slumped 305.58% in 2024 and surged 143.7% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $221.0 million in 2022, then dropped by 10.86% to $197.0 million in 2023, then sank by 305.58% to -$405.0 million in 2024, then jumped by 143.7% to $177.0 million in 2025, then tumbled by 110.73% to -$19.0 million in 2026.
• Per Business Quant, the three latest CL Capital Expenditures figures stand at -$19.0 million (Q1 2026), $177.0 million (Q4 2025), and $155.0 million (Q3 2025).